Turbine

Executive Summary

Turbine is a Hungarian biotechnology company leveraging artificial intelligence to transform drug discovery. Its proprietary platform, the Virtual Lab, simulates biological experiments to generate mechanistic hypotheses at scale, with a focus on oncology and immunology. By accelerating the identification of promising drug targets and improving clinical translatability, Turbine aims to reduce the high failure rate in drug development. Founded in 2015 and based in Budapest, the company operates in the AI/machine learning category and is privately held. While financial details are undisclosed, Turbine's approach addresses critical bottlenecks in preclinical research, positioning it as a potential partner for pharmaceutical firms seeking to enhance R&D productivity.

Upcoming Catalysts (preview)

• Q3 2026Pharmaceutical partnership or licensing deal45% success
• Q3 2026Series B funding round55% success
• Q3 2026Publication of validation data in a peer-reviewed journal60% success